Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20956641 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Condition: Non-melanomatous Skin Cancer
Intervention: Drug: celecoxib

Study has passed its completion date and status has not been verified in more than two years.